Loading stock data…
ICU Medical, Inc. (ICUI)
$147.93-0.34 (-0.23%)
After Hours$147.93+0.00 (+0.00%)· Last close Jun 29
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ICU Medical, Inc. in the Healthcare sector is trading at $147.93 with a market capitalization of $3.3B. Wall Street consensus targets $172.50 (8 analysts), implying a +16.6% move over the next 12 months. The stock is currently 8% below its 52-week high of $160.29, remaining 9.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +16.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $530.23M↓ | $540.70M↑ | $536.99M↓ | $548.87M↓ | $604.70M |
| Gross Profit | $206.23M↑ | $202.99M↑ | $200.88M↓ | $208.06M↓ | $210.11M |
| Operating Income | $30.38M↑ | $26.09M↓ | $26.86M↑ | $26.80M↓ | $29.59M |
| Net Income | $30.13M↑ | -$15.73M↓ | -$3.40M↓ | $35.34M↑ | -$15.48M |
Peer Comparison
JNJUNHPFE
Fundamentals
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroCla...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.26B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
70.17
Beta
Defensive asset. Lower volatility than the S&P 500.
0.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.19%
Volume
Today's trading volume
329,944
Recent News
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 9.5% over the past six months while the S&P 500 was up 6.2%.
ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?
ICU Medical has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $142.98. The stock also fell short of the S&P 500’s 6.3% gain during that period.
ICUI or MDLN: Which Is the Better Value Stock Right Now?
ICUI vs. MDLN: Which Stock Is the Better Value Option?
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ICU Medical (NASDAQ:ICUI) and the rest of the medical devices & supplies - cardiology, neurology, vascular stocks fared in Q1.
ICU Medical (ICUI) Stock Valuation Check After Recent Momentum And Discount To Estimated Fair Value
Recent price move puts ICU Medical in focus ICU Medical (ICUI) has drawn attention after a recent price move, with its stock closing at US$142.20 and showing positive returns over the past month and past 3 months. This has prompted closer scrutiny from investors. The company reports annual revenue of US$2.16b and net income of US$46.34m, with revenue and net income growth figures available. These provide some concrete fundamentals to weigh against the recent share performance. See our latest...